advertisement
11.4 Prostaglandins (21)
Showing records 1 to 21
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins14093 Additional reduction in intraocular pressure achieved with latanoprost in normal-tension glaucoma patients previously treated with unoprostone
Enoki M; Saito J; Hara M; Uchida T; Sagara T; Nishida T
Japanese Journal of Ophthalmology 2006; 50: 334-337
14222 A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension
Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
Clinical Therapeutics 2006; 28: 552-559
14097 Effects of latanoprost and betaxolol on cardiovascular and respiratory status of newly diagnosed glaucoma patients
Erkin EF; Celik P; Kayikcioglu O; Deveci HM; Sakar A
Ophthalmologica 2006; 220: 332-337
14258 Selection of therapeutic modality by four-week latanoprost followed by additional timolol-gel ophthalmic solution
Hashimoto T; Hara T; Tsuru T
Japanese Journal of Clinical Ophthalmology 2006; 60: 757-759
14253 Effect of topical levobunolol on latanoprost nonresponders
Kanno M; Yamashita H
Japanese Journal of Clinical Ophthalmology 2006; 60: 1025-1028
14080 Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial
Maruyama K; Shirato S
Journal of Glaucoma 2006; 15: 341-345
14126 A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension
Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
Clinical Therapeutics 2006; 28: 332-339
14020 Effect of previous argon laser trabeculoplasty on the ocular hypotensive action of latanoprost
Arranz-Marquez E; Teus MA
Graefe's Archive for Clinical and Experimental Ophthalmology 2006; 244: 1073-1076
14077 Efficacy of first- or second-line latanoprost on intraocular pressure and ocular symptoms in patients with open-angle glaucoma or ocular hypertension
Baudouin C; Rouland JF; Nordmann JP; Bron A; Pelen F
Journal Français d'Ophtalmologie 2006; 29: 615-624
14024 Effect of additive preoperative latanoprost treatment on the outcome of filtration surgery
Berthold S; Pfeiffer N
Graefe's Archive for Clinical and Experimental Ophthalmology 2006; 244: 1029-1034
14204 Intraocular pressure-lovering effect and safety of travoprost 0.004% and latanoprost 0.005% for the treatment of chronic angle closure glaucoma
Chew PTK; Pongpun PR; Euswas A; Lu D-W; Chua J; Hui S-P; Rait J; Goldberg I; Li B
Asian Journal of Ophthalmology 2006; 8: 13-19
14254 Changes in eyelid and cilia after switching from latanoprost to unoprostone
Izumi M; Inoue K; Wakakura M; Inouye J; Matsuo H; Hara T; Tomita G
Japanese Journal of Clinical Ophthalmology 2006; 60: 837-841
14096 Cystoid macular edema in a pseudophakic patient after several glaucoma procedures. Is local therapy with bimatoprost the reason?
Kruse P; Rieck P; Sherif Z; Liekfeld A
Klinische Monatsblätter für Augenheilkunde 2006; 223: 534-537
14022 Neuroprotective effect of latanoprost on rat retinal ganglion cells
Kudo H; Nakazawa T; Shimura M; Takahashi H; Fuse N; Kashiwagi K; Tamai M
Graefe's Archive for Clinical and Experimental Ophthalmology 2006; 244: 1003-1009
14032 The prostanoid EP2 receptor agonist butaprost increases uveoscleral outflow in the cynomolgus monkey
Nilsson SF; Drecoll E; Lutjen-Drecoll E; Toris CB; Krauss AH; Kharlamb A; Nieves A; Guerra T; Woodward DF
Investigative Ophthalmology and Visual Science 2006; 47: 4042-4049
14050 The effects of prostaglandin analogues on prostanoid EP1, EP2, and EP3 receptor-deficient mice
Ota T; Aihara M; Saeki T; Narumiya S; Araie M
Investigative Ophthalmology and Visual Science 2006; 47: 3395-3399
14272 Association between topical prostaglandin analog use and development of choroidal neovascular membranes in patients with concurrent glaucoma and age-related macular degeneration
Scherer WJ
Journal of Ocular Pharmacology and Therapeutics 2006; 22: 139-144
14271 Effects of a prostaglandin DP receptor agonist, AL-6598, on aqueous humor dynamics in a nonhuman primate model of glaucoma
Toris CB; Zhan G-L; Feilmeier MR; Camras CB; McLaughlin MA
Journal of Ocular Pharmacology and Therapeutics 2006; 22: 86-92
14144 Effects of travoprost 0.004% compared with latanoprost 0.005% on the intraocular pressure of normal dogs
Carvalho AB; Laus JL; Costa VP; Barros PS; Silveira PR
Veterinary Ophthalmology 2006; 9: 121-125
14002 Allergic contact dermatitis caused by latanoprost ophthalmic solution
Lai CH; Lai IC; Chi CC
European Journal of Ophthalmology 2006; 16: 627-629
14202 Prostaglandin analogues reduce the ibopamine provocative test specificity in glaucoma
Magacho L; Costa ML; Lima FE; Magacho B; de Avila MP
Arquivos Brasileiros de Oftalmologia 2006; 69: 193-196